EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unintended pregnancy and contraception use among African women living with HIV: Baseline analysis of the multi-country US PEPFAR PROMOTE cohort

Jim Aizire iD, Nonhlanhla Yende-Zuma, Sherika Hanley, Teacler Nematadzira iD, Mandisa M Nyati, Sufia Dadabhai, Lameck Chinula, Catherine Nakaye, Mary Glenn Fowler, Taha Taha, US-PEPFAR PROMOTE Cohort Study team

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0290285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jim Aizire und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America. Hauptthemen laut MEDLINE: Pregnancy, Unplanned, HIV Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, President’s Emergency Plan for AIDS Relief, JHU-Uganda CTU Makerere University-Johns Hopkins University (MU-JHU) Research Collaboration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

About 90% of unintended pregnancies are attributed to non-use of effective contraception–tubal ligation, or reversible effective contraception (REC) including injectables, oral pills, intra-uterine contraceptive device (IUCD), and implant. We assessed the prevalence of unintended pregnancy and factors associated with using RECs, and Long-Acting-Reversible-Contraceptives (LARCs)–implants and IUCDs, among women living with HIV (WLHIV) receiving antiretroviral therapy (ART).

Methods

We conducted cross-sectional analyses of the US-PEPFAR PROMOTE study WLHIV on ART at enrollment. Separate outcome (REC and LARC) modified-Poisson regression models were used to estimate prevalence risk ratio (PRR) and corresponding 95% confidence interval (CI).

Results

Of 1,987 enrolled WLHIV, 990 (49.8%) reported their last/current pregnancy was unintended; 1,027/1,254 (81.9%) non-pregnant women with a potential to become pregnant reported current use of effective contraception including 215/1,254 (17.1%) LARC users. Compared to Zimbabwe, REC rates were similar in South Africa, aPRR = 0.97 (95% CI: 0.90–1.04), p = 0.355, lower in Malawi, aPRR = 0.84 (95% CI: 0.78–0.91), p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy, UnplannedHIV InfectionsPregnancyChildHumansFemaleCross-Sectional StudiesContraceptionSouth AfricaContraception Behavior

Autor:innen und Institutionen

  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.
  • Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • South Africa Medical Research Council (SAMRC)-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
  • Centre for the AIDS Programme of Research in South Africa (CAPRISA), Umlazi Clinical Research Site, Durban, South Africa.
  • University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.
  • Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

ORCID-Profile: Jim Aizire, Teacler Nematadzira

Förderung

  • NIAID NIH HHS
  • President’s Emergency Plan for AIDS Relief
  • JHU-Uganda CTU Makerere University-Johns Hopkins University (MU-JHU) Research Collaboration
  • The Johns Hopkins University-Blantyre Clinical Trials Unit
  • The University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
  • University of Zimbabwe College of Health Sciences Clinical Trials Research Centre
  • PHRU KARABELO Clinical Trials Unit for NIAID Networks
  • Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment

Zitieren

APA

Aizire, J., Yende-Zuma, N., Hanley, S., Nematadzira, T., Nyati, M. M., Dadabhai, S., Chinula, L., Nakaye, C., Fowler, M. G., Taha, T., & US-PEPFAR PROMOTE Cohort Study team (2024). Unintended pregnancy and contraception use among African women living with HIV: Baseline analysis of the multi-country US PEPFAR PROMOTE cohort. PLOS ONE. https://doi.org/10.1371/journal.pone.0290285

Vancouver

Aizire J, Yende-Zuma N, Hanley S, Nematadzira T, Nyati MM, Dadabhai S, et al. Unintended pregnancy and contraception use among African women living with HIV: Baseline analysis of the multi-country US PEPFAR PROMOTE cohort. PLOS ONE. 2024. doi:10.1371/journal.pone.0290285

BibTeX
@article{Aizire2024,
  author = {Aizire, Jim and Yende-Zuma, Nonhlanhla and Hanley, Sherika and Nematadzira, Teacler and Nyati, Mandisa M and Dadabhai, Sufia and Chinula, Lameck and Nakaye, Catherine and Fowler, Mary Glenn and Taha, Taha and US-PEPFAR PROMOTE Cohort Study team, US-PEPFAR PROMOTE Cohort Study team},
  title = {Unintended pregnancy and contraception use among African women living with HIV: Baseline analysis of the multi-country US PEPFAR PROMOTE cohort},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0290285}
}
Kostenlos starten →